)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Medexus Pharmaceuticals (MDP) investor relations material
Medexus Pharmaceuticals Canaccord Genuity’s 45th Annual Growth Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Canaccord Genuity’s 45th Annual Growth Conference summary13 Aug, 2025
Company overview and mission
Focused on rare disease orphan drugs with significant impact on patient outcomes.
Operates in the US and Canada with about $100M in revenue and 15 marketed products.
Management holds significant ownership and emphasizes commercial execution over drug development.
Business model centers on acquiring and licensing late-stage or registered drugs for commercialization.
Organic growth and portfolio expansion are driven by business development, with minimal R&D risk.
Key products and growth catalysts
Grafapix (triosulfan) recently launched, expected to more than double revenue and improve gross margin.
Grafapix targets allogeneic stem cell transplantation, showing strong clinical and commercial uptake.
Orphan drug exclusivity for Grafapix provides seven years of market protection.
Other key products include Xinity for hemophilia B and Risuvo, both holding strong market shares.
Regulatory and reimbursement milestones, such as MTAP approval, enhance product growth potential.
Financial performance and outlook
Revenue growth plateaued during Grafapix registration but is expected to accelerate significantly.
Recent quarters show positive EBITDA, with a rebound after initial launch costs for Grafapix.
Company trades at less than 1x revenue and 4.4x adjusted EBITDA, seen as undervalued.
Balance sheet is strong with low net debt and 32M shares outstanding.
Vision to exceed $500M in revenue, leveraging cash flow from Grafapix to fund further acquisitions.
Canadian Graphipex uptake insights for US?
Medexis's M&A strategy for new products?
When will Graphipex become EBITDA accretive?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Medexus Pharmaceuticals earnings date
Q2 20265 Nov, 2025
Next Medexus Pharmaceuticals earnings date
Q2 20265 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the specialty areas of rheumatoid arthritis, asthma/allergy, psoriasis/dermatology, and gastrointestinal disorders through its sales and marketing activities and an expanding network of professional relationships. The company markets its products through sales representatives.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage